NDAINJECTIONINJECTABLE
Approved
Jan 1989
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 9h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Cefpiramide Sodium is a third-generation cephalosporin antibiotic administered via injection for bacterial infections. It provides broad-spectrum coverage against gram-positive and gram-negative organisms. The drug works by inhibiting bacterial cell wall synthesis through beta-lactam mechanism.
LOE Approaching
Product faces imminent loss of exclusivity with declining market relevance; commercial team size likely minimal and focused on managed decline.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Cefpiramide Sodium offers minimal career growth opportunity; positions are limited to post-patent management, generic optimization, or hospital account support. This product is suitable only for professionals seeking stable, non-growth roles in legacy product management.
Generic Account ManagerSupply Chain Specialist
Worked on CEFPIRAMIDE SODIUM at Thayer Medical? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.